Categories Cancer

Gut microbiome a potential biomarker for nivolumab efficacy in advanced gastric cancer

Gut microbiome a potential biomarker for nivolumab efficacy in advanced gastric cancer January 21, 2021 2 min read Source/Disclosures Source: Sunakawa Y, et al. Abstract 161. Presented at: Gastrointestinal Cancers Symposium (virtual meeting); Jan. 15-17, 2021. Disclosures: Bristol Myers Squibb and Ono Pharmaceuticals funded this study. Sunakawa reports consultant/advisory roles with Bristol Myers Squibb Japan, […]

Read More